Celcuity (CELC) Other financing activities (2017 - 2025)
Celcuity's (CELC) quarterly Other financing activities came in at -$1.7 million in Q4 2025, down 111.45% YoY from $14.6 million in Q4 2024, and down 170.77% on a QoQ basis from $2.4 million in Q3 2025.
Celcuity (CELC) Other financing activities (2017 - 2025) Analysis & Trends
Celcuity (CELC) has 8 years of Other financing activities data on file, last reported at -$1.7 million in Q4 2025.
- Quarterly Other financing activities fell 111.45% year-over-year to -$1.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $711000.0 (down 97.51% YoY) and the FY2025 annual result came in at $711000.0, down 95.18% from the prior year.
- Other financing activities eased to -$1.7 million in Q4 2025, from $2.4 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $14.6 million in Q4 2024 to a low of -$5.6 million in Q2 2025.
- A 5-year average of $1.9 million and a median of $27629.5 in 2021 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2023 — Other financing activities slumped 164.53% — and 2024, when it soared 17756.16%.
- Tracing CELC's Other financing activities over 5 years: stood at $7505.0 in 2021, then surged by 1607.91% to $128179.0 in 2022, then tumbled by 164.53% to -$82719.0 in 2023, then soared by 17756.16% to $14.6 million in 2024, then tumbled by 111.45% to -$1.7 million in 2025.
- The last three Other financing activities figures came in at -$1.7 million (Q4 2025), $2.4 million (Q3 2025), and -$5.6 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Celcuity | 4.50 Bn | 4.50 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.67 Mn |
| Dec 31, 2025 | -1.67 Mn |
| Sep 30, 2025 | 2.36 Mn |
| Sep 30, 2025 | 2.36 Mn |
| Jun 30, 2025 | -5.58 Mn |
| Jun 30, 2025 | -5.58 Mn |
| Mar 31, 2025 | 5.60 Mn |
| Mar 31, 2025 | 5.60 Mn |
| Dec 31, 2024 | 14.61 Mn |
| Dec 31, 2024 | 14.61 Mn |
| Mar 31, 2024 | 14.00 Mn |
| Mar 31, 2024 | 14.00 Mn |
| Dec 31, 2023 | -82,719.00 |
| Dec 31, 2023 | -82,719.00 |
| Sep 30, 2023 | 44,002.00 |
| Sep 30, 2023 | 44,002.00 |
| Jun 30, 2023 | 113,640.00 |
| Jun 30, 2023 | 113,640.00 |
| Mar 31, 2023 | 127,922.00 |
| Mar 31, 2023 | 127,922.00 |